SEC Form 4 · accession 0001209191-15-051537
Adamas Pharmaceuticals Inc · ADMS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rajiv Patni
Officer — Chief Medical Officer
Period of report
Jun 8, 2015
Accepted (ET)
Jun 9, 2015 · 6:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001328143
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $19.14 | Jun 8, 2015 | A | 120,000 | A | — | Jun 7, 2025 | Common Stock | 120,000 | 120,000 | D |
Explanation of responses
- F1The Option shares shall vest as follows: 25% of the option shares will vest on the 12 month anniversary of June 8, 2015, and the balance will vest in equal monthly installments over the next 36 months, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of each such date.